Sponsor pipeline

Shanghai Bovax Biotechnology Co., Ltd. clinical trial pipeline

Get alerts when Shanghai Bovax Biotechnology Co., Ltd.'s trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-16

What changed in the last 30 days

1 trial changed in the last 30 days: 0 stopped, 0 with notable changes, 1 with a minor change only.

  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.

Active trials by phase

Phase 2
1
Phase 3
2
Not charted: 1 active trial with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Active trials

NCT IDTitleConditionStatusUpdated
Phase 3
NCT04422366 Evaluate the Efficacy, Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in… Cervical Cancer Recruiting 2024-06-07
NCT06465914 A Phase III Study to Evaluate the Efficacy, Immunogenicity and Safety of the 9-valent HPV… Genital Wart Active, Not Recruiting 2024-12-12
Phase 2
NCT06756269 To Evaluate the Safety and Immunogenicity of 15-valent HPV Recombinant Vaccine in Chinese… HPV Infection Recruiting 2025-12-17
Not specified
NCT05371353 Immune Persistence After the Whole Vaccination Shcedule With Recombination Quadrivalent… HPV Infections Recruiting 2024-04-17

Disease areas by active trials

Cervical Cancer (2) · Colorectal Cancer (1)

Get alerts when Shanghai Bovax Biotechnology Co., Ltd.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free